Ayahuasca Podcast: Joe Moore β Safe Access, Breathwork and Building a Psychedelic Informed World
In this episode of Ayahuasca Podcast host Sam Believ has a conversation with Joe Moore, co-founder & CEO of Psychedelics Today. Joe is a longtime voice in psychedelic education and media (700+ interviews), and the creator of the Vital year-long training program focused on psychedelic-informed practice and harm reduction. iHeart Spotify The post Ayahuasca Podcast: Joe Moore β Safe Access, Breathwork and Building a Psychedelic Informed World appeared first on Psychedelics Today.
External link. We are not responsible for the content.
Read more βMore From Psychedelics Today
Inclius Alvariousβs Place Within Indigenous Society
A look at Sonoran Desert toad medicine through the lens of indigenous sovereignty, ecological strain, and the debate ...
Shane Mauss β Comedy and Molecules β Episode 14
Shane Mauss is an award-winning comedian (Conan, Kimmel, Comedy Central, Prime) with a fondness for interviewing scie...
Ketamine-Assisted Couple Therapy Training by Enamory
This educational workshop is the first step toward certification in the Enamory model of Ketamine-Assisted Couple The...
Latest News
Where Does the World Go to Dance? Probs These EDM Festivals
A global guide to the festivals worth planning for. [...] Read More... The post Where Does the World Go to Dance? Pro...
Can you kill a bad trip?: 5 Questions for emergency physician Gregory Yates
Yates discusses experimental attempts to end a psychedelic trip early.
Psychedelic Faeries Take on Prohibition and Authoritarianism
Plus psychedelics and telepathy, ego death for the rich, and our brain on Chat GPT [...] Read More... The post Psyche...
Introduction to Trip Sitting
The Art and Science of Holding Psychedelic Space
Heartbreak is a Bad Trip
Oli Genn-Bash describes how the aftermath of a sudden breakup felt like a prolonged βbad tripβ, as well as the potent...
New Orleans Hosts Psychedelic Research Conference Double-Header
Over the last week in February, more than 200 people from psychedelic drug development companies, clinical researcher...